Summary Details

Stock Exchange Listing
Primary country listingGBR
SectorDiagnostics & Research
Activities in the UK, US and Middle-EastANGLE PLC was incorporated on December 04, 2003 in England and Wales. It is a commercially driven specialist medical diagnostic company with products in cancer diagnostics and foetal health. The Company is commercializing a platform technology that can capture cells circulating in blood, such as cancer cells, even when it is rare in number as one cell in one billion blood cells, and harvest the cells for analysis. The Company has developed Parsortix cell separation device, which can capture rare circulating tumour cells (CTCs) in cancer patient blood.
EPICAGL
 
Overview from annual report:30/04/201630/04/2015
Ave. no. employees (excl. Dir.) 28 26
ROCE(%)-0.77-0.31
 
Latest results - annual report30/04/201630/04/2015
Turnover(£m)0.360
Pretax profit(£m)-5.43-3.87
EPS (Norm Dil.)(p)-7.93-8.12
Dividend(p)00
 
Figures at last close:
Closing share price(£)
No. of shares in issue(m)74.82
Market capitalisation(£m)46.95

Investis

Copyright Investis Ltd. All rights reserved. Data and charts may be delayed by 15 minutes or more. Financial data provided by Morningstar. By using this web page you agree to our terms of use and to the terms of our privacy statement.

 
Site map |  Email alerts |  Contact us |